375
Participants
Start Date
April 19, 2016
Primary Completion Date
January 5, 2018
Study Completion Date
March 27, 2018
SOF/VEL
SOF/VEL (400/100 mg) FDC tablet administered orally once daily
Chulalongkorn Hospital, Bangkok
Ramathibodi Hospital Mahidol University, Bangkok
Siriraj Hospital, Bangkok
Hospital Tengku Ampuan Afzan, Kuala Pahang
Maharaj Nakhon Chiangmai Hospital, Chiang Mai
University of Malaya, Kuala Lumpur
Songklanagarind Hospital, Songkhla
Bach Mai Hospital, Hanoi
National Hospital for Tropical Disease, Hanoi
Beijing Ditan Hospital, Chaoyang
Peking University First Hospital, Beijing
Peking University People's Hospital, Beijing
Beijing Friendship Hospital Affiliate of Capital Medical University, Beijing
Shengjing Hospital of China Medical University, Liaoning
National University Hospital, Singapore
The First Hospital of Jilin University, Jilin
Singapore General Hospital, Singapore
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai
Shanghai Renji Hospital, Shanghai
Shanghai Ruijin Hospital, Huangpu
Shanghai Public Health Clinical Center, Hongkou
The Second Hospital of Nanjing, Jiangsu
Jinan Infectious Disease Hospital, Jinan
The First Affiliated Hospital of NanChang University, Nanchang
The Second Affiliated Hospital of Chongqing Medical University, Chongqing
Xiangyan Hospital, Central South University, Changsha
The 2nd Xiangya Hospital of Central South University, Hunan
Tongji Hospital Affiliated to Tongji Medicine University, Wuhan
Henan Province People's Hospital, Zhengzhou
Guangzhou Eighth People's Hospital, Guangdong
Nanfang Hospital of Southern Medical University, Guangzhou
The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou
The First Affiliated Hospital of Guangxi Medical University, Nanning
The People's Hospital of Hainan Province, Hainan
West China Hospital, Sichuan University, Chengdu
Ho Chi Minh City Hospital for Tropical Diseasees, Ho Chi Minh City
People's Hospital 115, Ho Chi Minh City
The 3rd Hospital of Hebei Medical University, Shijiazhuang
Lead Sponsor
Gilead Sciences
INDUSTRY